Timm S, Gassel H-J, Thiede A
Zentrum für Operative Medizin, Chirurgische Klinik I, Universitätsklinikum Würzburg.
Zentralbl Chir. 2007 Aug;132(4):328-35. doi: 10.1055/s-2007-981201.
Due to their anatomical position, the tendency of early infiltrative growth and their poor prognosis without treatment, klatskin tumors are challenging concerning diagnosis and therapy. In contrast to other tumors of the gastrointestinal tract, for which exact diagnostic and stage dependent therapeutic guidelines could be formulated, clear recommendations for klatskin tumors are missing. Thus, survival rates after local resection, e. g. resection of the bile duct bifurcation alone, show high rates of R1/2 resection and early tumor recurrence. With an additional hepatic resection formally curative resections and long-term survival can be improved. Extended liver resections including the portal vein provide the highest rates of R0 resections for hilar carcinomas of the extrahepatic bile duct. Survival rates after liver transplantation for klatskin tumors are not yet convincing. Promising first results have been reported for the combination of neoadjuvant treatment and liver transplantation and might show future perspectives for the treatment of klatskin tumors.
由于其解剖位置、早期浸润性生长的倾向以及未经治疗时预后较差,肝门部肿瘤在诊断和治疗方面具有挑战性。与其他胃肠道肿瘤不同,对于后者可以制定精确的诊断和依赖分期的治疗指南,而对于肝门部肿瘤却缺乏明确的建议。因此,局部切除后的生存率,例如仅切除胆管分叉处,显示出较高的R1/2切除率和早期肿瘤复发率。进行额外的肝切除可以提高根治性切除率和长期生存率。包括门静脉在内的扩大肝切除对于肝外胆管肝门部癌的R0切除率最高。肝门部肿瘤肝移植后的生存率尚不令人信服。新辅助治疗与肝移植联合应用已报道了有希望的初步结果,可能为肝门部肿瘤的治疗展现未来前景。